FENC – fennec pharmaceuticals inc. (US:NASDAQ)
Stock Stats
News
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $13.00 price target on the stock.
Investing in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago would have delivered you a 38% gain [Yahoo! Finance]
Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025
Form 8-K FENNEC PHARMACEUTICALS For: Mar 10
Form 4 FENNEC PHARMACEUTICALS For: Mar 05 Filed by: Raykov Rosty
Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty
Form 4 FENNEC PHARMACEUTICALS For: Feb 28 Filed by: Andrade Robert
Form 4 FENNEC PHARMACEUTICALS For: Feb 28 Filed by: Raykov Rosty
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.